Youn et al. demonstrated that the ratio of Treg cells to Lox-1+ MDSCs was positively correlated with anti-PD-1 efficacy in non-small cell lung cancer (NSCLC) (Kim et al., 2019). The gene discussed is PDCD1; the disease is non-small cell lung carcinoma.